A recent U.K. study has shown promising ten-year outcomes for focal therapy in prostate cancer treatment, utilized by figures like Jeremy Clarkson. Among 3,477 men treated, only 0.13% died from prostate cancer, and 3.3% experienced metastasis, suggesting that focal therapy can be effective while reducing serious side effects compared to traditional treatments like surgery. However, the study was not randomized, and its availability remains limited in the NHS, despite the potential to benefit up to 15,000 patients annually. Ongoing monitoring and trials are essential as access issues persist and more long-term data is required to solidify these findings.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://okdiario.com/metabolic/en/health/the-prostate-cancer-treatment-a-famous-presenter-chose-cuts-the-risk-of-side-effects-and-it-is-already-available-where-most-men-are-not-offered-it-29858/
